There have been no reported cases of overdose with MoviPrep®. Purposeful or gross accidental ingestion of more than the recommended dose of MoviPrep® might be expected to lead to severe electrolyte disturbances, including hyponatremia and/or hypokalemia, as well as dehydration and hypovolemia, with signs and symptoms of these disturbances. The patient who has taken an overdose should be monitored carefully, and treated symptomatically for complications until stable.

MoviPrep® is contraindicated in patients who have had a severe hypersensitivity reaction to any of its components.

Bookmark this page: